Related Experiment Video
Updated: Feb 10, 2026
07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
25.2K
Congenital Calvarial Hemangioma.
Michal Brichacek1, Abdul Naeem2, Guido Filler3
1Section of Plastic Surgery, University of Manitoba, Winnipeg, Manitoba.
The Journal of Craniofacial Surgery
|May 10, 2018
Summary
Congenital calvarial hemangioma, a rare skull lesion, can be effectively treated with propranolol therapy. This case study highlights propranolol as a viable alternative to surgery for managing this condition.
Area of Science:
- Pediatric Neurosurgery
- Vascular Anomalies
- Pharmacological Treatment
Background:
- Congenital calvarial hemangiomas are rare vascular tumors of the skull.
- Diagnosis typically involves imaging and biopsy.
- Surgical resection has been the traditional treatment.
Observation:
- A 2-year-old boy presented with a growing parietal skull mass.
- Imaging revealed a benign-appearing lesion with characteristic trabeculations.
- Histopathology confirmed a cavernous hemangioma.
Findings:
- Propranolol therapy was administered for over three years.
- The hemangioma showed a significant reduction in size during treatment.
- MRI confirmed mass reduction post-propranolol therapy.
Implications:
- Propranolol offers a non-surgical treatment option for congenital calvarial hemangioma.
- This approach may be suitable for select cases, avoiding surgical risks.
- Early consideration of propranolol is important for managing skull lesions.
